Middle East and North Africa Aesthetic Injectable Fillers Market Report Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2036

Middle East And North Africa Aesthetic Injectable Fillers Market

Market Size in USD Million

CAGR : 9.33 %

Bar chart comparing the Middle East And North Africa Aesthetic Injectable Fillers Market size in 2024 - 347.92 and 2036 - 1005.45, highlighting the projected market growth.

USD 347.92 Million USD 1,005.45 Million 2024 2036

Forecast Period	2025 –2036
Market Size (Base Year)	USD 347.92 Million
Market Size (Forecast Year)	USD 1,005.45 Million
CAGR	9.33 %
Major Markets Players	Allergan Aesthetics (AbbVie) GALDERMA Merz Pharma (Germany) Hugel Inc. LG Chem

Middle East and North Africa Aesthetic Injectable Fillers Market Segmentation, By Product Type (Natural Aesthetic Injectable Fillers, and Synthetic Aesthetic Injectable Fillers), By Type (Biodegradable Aesthetic Injectable Fillers, Non-Biodegradable Aesthetic Injectable Fillers), By Application (Facial Line Correction, Lip Enhancement, Face Lift, Rhinoplasty, Scar Treatment, Sagging Skin, Cheek Depression, Reconstructive Surgery, Aesthetic Restoration, Dentistry, Chin Augmentation, Lipoatrophy Treatment, Skin Smoothing, Earlobe Rejuvenation, Others), By Drug Type (Branded, and Generic), By End User (Dermatology Clinics, Hospitals, Ambulatory Surgical Centers, and Others), By Distribution Channel (Direct Tender/Direct Distribution, Drug Stores, Online Pharmacy, and Others) - Industry Trends and Forecast to 2036

Middle East and North Africa Aesthetic Injectable Fillers Market Size

The Middle East and North Africa Aesthetic Injectable Fillers Market was valued at USD 347.92 Million in 2024 and is expected to reach USD 1,005.45 Million by 2036
During the forecast period of 2025 to 2036 the market is likely to grow at a CAGR of 9.33%, primarily driven by rising demand for non-surgical facial rejuvenation, expanding aging population, and increased social acceptance of cosmetic enhancements across both developed and emerging markets
This growth is supported by key factors such as advancements in hyaluronic acid and collagen-stimulating technologies, increasing accessibility of aesthetic clinics, and growing patient preference for personalized, natural-looking results with minimal downtime. Regulatory approvals of new products, influencer-driven aesthetic trends, and the rise of medical tourism are further accelerating Middle East & North Africa market expansion

Middle East and North Africa Aesthetic Injectable Fillers Market Analysis

The Middle East and North Africa Aesthetic Injectable Fillers Market is witnessing consistent growth, driven by rising disposable incomes, increasing awareness of cosmetic procedures, and growing acceptance of minimally invasive aesthetic treatments across countries. Rapid urbanization, changing beauty standards, and a young population seeking early intervention for aging signs are key factors fueling demand. However, challenges such as high treatment costs and regulatory variations across countries persist
The shift toward natural, biocompatible, and long-lasting filler products is a primary driver, supported by advancements in hyaluronic acid and collagen-stimulating technologies. The increasing availability of skilled practitioners and expanding aesthetic clinic networks are enabling wider access to injectable treatments. Social media influence and rising medical tourism within the region are further accelerating market adoption
UAE dominates the regional demand due to large populations, growing middle-class consumer bases, and increasing investments in healthcare infrastructure. Saudi Arabia is the highest growing country in the Middle East & North Africa market, recognized globally for aesthetic innovations and high per capita spending on cosmetic procedures, driven by growing beauty consciousness and expanding medical tourism hubs like Thailand and Malaysia
Major manufacturers are focusing on localizing production and forming strategic partnerships with regional distributors to improve market penetration. Product innovation with formulations tailored to diverse skin types and preferences is a key strategy. Regulatory bodies across Middle East & North Africa are gradually streamlining approval processes, but variations in compliance requirements demand strong quality assurance frameworks. Digital marketing and influencer endorsements are playing an increasing role in consumer education and engagement
Natural aesthetic injectable fillers segment is expected to dominate with 70.13% market share, owing to growing consumer preference for biocompatible, minimally invasive treatments that deliver natural-looking results with fewer side effects.

Report Scope and Middle East and North Africa Aesthetic Injectable Fillers Market Segmentation

Attributes	Middle East and North Africa Aesthetic Injectable Fillers Key Market Insights
Segments Covered	By Product Type: Natural Aesthetic Injectable Fillers, and Synthetic Aesthetic Injectable Fillers By Type: Biodegradable Aesthetic Injectable Fillers, Non-Biodegradable Aesthetic Injectable Fillers By Application: Facial Line Correction, Lip Enhancement, Face Lift, Rhinoplasty, Scar Treatment, Sagging Skin, Cheek Depression, Reconstructive Surgery, Aesthetic Restoration, Dentistry, Chin Augmentation, Lipoatrophy Treatment, Skin Smoothing, Earlobe Rejuvenation, Others By Drug Type: Branded, and Generic By End User: Dermatology Clinics, Hospitals, Ambulatory Surgical Centers, and Others By Distribution Channel: Direct Tender/Direct Distribution, Drug Stores, Online Pharmacy, and Others
Countries Covered	Middle East & North Africa UAE Saudi Arabia Egypt Israel Bahrain Turkey Kuwait Oman Qatar Rest of Middle East & North Africa
Key Market Players	Allergan Aesthetics (AbbVie) (United States) GALDERMA (Switzerland) Merz Pharma (UAE) Hugel Inc. (Israel) LG Chem (Israel) Medytox Inc. (Israel) IBSA Institut Biochimique SA (Switzerland) Laboratoires Vivacy (France) Prollenium Medical Technologies (Canada) Croma (Austria) FillMed Laboratories (France) Humedix (Israel) TEOXANE (Switzerland) Sinclair (United Kingdom) Bioscience (UAE) Amalian (UAE) Bioxis Pharmaceuticals (France) Mesoestetic (Spain) Zhejiang Jingjia Medical Technology Co., Ltd. (UAE) Jalupro (Italy) BIOPLUS CO. LTD. (Israel) Shanghai Reyoungel Medical Technology Company Limited (UAE) Contura International Ltd (United Kingdom) Tiger Aesthetics Medical, LLC (United States) Huons Middle East & North Africa (Israel) Vida Srl. (Italy) Sosum Middle East & North Africa (Israel) Revance (United States) Petrone Group (Italy)
Market Opportunities	Expansion in emerging markets Product innovation and personalized solutions Broadening into additional therapeutic areas
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, pricing analysis, brand share analysis, consumer survey, demography analysis, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Middle East and North Africa Aesthetic Injectable Fillers Market Trends

“Technological Advancements, Personalization, and Clean Aesthetic Solutions”

One prominent trend in the Middle East and North Africa Aesthetic Injectable Fillers Market is the growing demand for personalized aesthetic treatments, driven by consumer preference for natural-looking results, age-specific skin concerns, and facial anatomy variations. Clinics and practitioners are increasingly adopting patient-specific injection protocols, advanced imaging, and facial mapping tools to deliver precision-based outcomes that match individual aesthetic goals
The market is witnessing increased adoption of next-generation dermal filler technologies, including hybrid fillers, HA-based biostimulators, and dual-action formulations that combine volumization with skin rejuvenation. These innovations improve clinical outcomes by offering longer-lasting effects, reduced downtime, and enhanced safety profiles. For example, RHA (Resilient Hyaluronic Acid) fillers and HA fillers infused with lidocaine or antioxidants are gaining popularity for their smooth integration and reduced post-treatment discomfort
In 2024, companies like Revance and Teoxane launched targeted filler products designed for high-mobility facial areas such as the perioral zone and under-eye region, addressing concerns of dynamic wrinkling and volume loss without compromising facial expressiveness. These formulations often incorporate cross-linked HA technologies for controlled diffusion and minimal swelling, appealing to both first-time users and experienced patients seeking subtle, refined enhancements
Major players are integrating AI-driven consultation platforms and AR-based preview tools into clinical practices, enabling practitioners to model expected outcomes and guide patients through their aesthetic journey. Simultaneously, manufacturers are using 3D printing and microfluidic technologies to develop consistent, high-purity filler products, improving batch quality and reducing injection variability
With growing awareness of product ingredients and long-term safety, there is increasing demand for ‘clean beauty’ injectables—fillers free from animal-derived components, artificial additives, and preservatives. Manufacturers are responding by investing in vegan-certified, non-GMO, and fully biodegradable formulations.
As regulatory bodies and end-users become more sophisticated, aesthetic injectable brands are prioritizing transparency, clinical validation, and ESG-aligned product development. This includes publishing peer-reviewed safety and efficacy data, implementing carbon-neutral production initiatives, and aligning brand messaging with sustainability and ethical treatment philosophies—helping build stronger consumer trust and brand loyalty across Middle East & North Africa markets

Middle East and North Africa Aesthetic Injectable Fillers Market Dynamics

Driver

“Growing Demand For Minimally Invasive Cosmetic Procedures”

Minimally invasive cosmetic procedures are rapidly gaining popularity across Middle East & North Africa markets, driven by shifting beauty ideals, rising aesthetic awareness, and a growing emphasis on subtle, natural-looking enhancements.
Aesthetic injectable fillers, in particular, offer an appealing alternative to surgical interventions due to their reduced downtime, lower complication rates, and cost-effectiveness.
This demand is further amplified by younger demographics increasingly seeking preventative treatments, as well as older populations desiring non-surgical anti-aging solutions.
In response, clinics and medical spas are expanding their offerings, while manufacturers continue to innovate with advanced, longer-lasting, and biocompatible filler formulations. The trend is further supported by technological advancements in application techniques and safety standards, making treatments more accessible and customizable.
As patient demand continues to rise, minimally invasive solutions are shaping the strategic priorities of providers and developers alike—firmly positioning themselves as a central growth driver in the Middle East and North Africa Aesthetic Injectable Fillers Market.

Opportunity

“Expansion In Emerging Markets”

The Middle East and North Africa Aesthetic Injectable Fillers Market is witnessing significant growth, particularly in emerging economies such as the Middle East & North Africa and Latin America. This expansion is fueled by a rising middle class with higher disposable incomes, growing awareness and acceptance of aesthetic treatments, and the widespread influence of social media and celebrity culture.
Companies are increasingly adopting region-specific strategies that cater to local cultural preferences and patient expectations — such as favoring subtler enhancements in East Asia and more pronounced contouring in Latin American markets.
The expansion into emerging markets presents a significant opportunity for the aesthetic injectable fillers market to achieve substantial growth by tapping into a large, new consumer base with increasing purchasing power and a growing interest in aesthetic enhancements

Restraint/Challenge

“High Cost Of Aesthetic Injectable Procedures”

The high cost of aesthetic injectable procedures remains a significant barrier to widespread adoption, especially in price-sensitive markets and among younger consumers. These treatments often require not only the initial injection but also regular maintenance sessions to sustain results, which can quickly accumulate into a substantial financial commitment.
The pricing is influenced by factors such as the type and brand of filler used, the expertise of the practitioner, and the geographic location of the clinic. For many potential patients, especially those without discretionary income or adequate insurance coverage, these costs can limit access and deter long-term use.
Moreover, the perception of injectable fillers as luxury or elective procedures adds to their exclusivity, reinforcing the notion that such treatments are beyond the reach of average consumers.
Despite growing demand, the high upfront and ongoing costs restrict the potential consumer base, posing a challenge for industry growth and encouraging providers to explore more cost-effective solutions or flexible payment options.

Middle East and North Africa Aesthetic Injectable Fillers Market Scope

The Middle East and North Africa Aesthetic Injectable Fillers Market is segmented into six notable segments based on product type, type, application, drug type, end users, and distribution channel.

• By Product Type

On the basis of product type, Middle East and North Africa Aesthetic Injectable Fillers Market is segmented into natural aesthetic injectable fillers, and synthetic aesthetic injectable fillers. In 2025, the natural aesthetic injectable fillers segment is expected to dominate with 70.13% market share, owing to growing consumer preference for biocompatible, minimally invasive treatments that deliver natural-looking results with fewer side effects.

Natural aesthetic injectable fillers is anticipated to gain traction with the CAGR of 9.4% during the forecast period of 2025 to 2036, driven by growing consumer preference for subtle, natural-looking enhancements, rising demand for biocompatible and biodegradable substances, and advancements in regenerative aesthetics.

• By Type

On the basis of type, the Middle East and North Africa Aesthetic Injectable Fillers Market is segmented into biodegradable aesthetic injectable fillers, and non-biodegradable aesthetic injectable fillers. In 2025, the biodegradable aesthetic injectable fillers segment is expected to dominate with 75.51% market share, due to their high safety profile, minimal long-term side effects, and widespread acceptance among both patients and practitioners. Their ability to naturally break down in the body over time reduces the risk of permanent complications, while continuous advancements in hyaluronic acid, calcium hydroxylapatite, and poly-L-lactic acid formulations enhance results and longevity.

The Hyaluronic Acid (HA) segment is projected to expand steadily with a CAGR of 9.51% as demand continues to rise for minimally invasive, biocompatible dermal fillers that offer hydration, volume restoration, and wrinkle reduction with minimal downtime.

• By Application

On the basis of application, the Middle East and North Africa Aesthetic Injectable Fillers Market is segmented into facial line correction, lip enhancement, face lift, rhinoplasty, scar treatment, sagging skin, cheek depression, reconstructive surgery, aesthetic restoration, dentistry, chin augmentation, lipoatrophy treatment, skin smoothing, earlobe rejuvenation, and others, In 2025, the facial line correction segment is expected to dominate with 31.58% market share, due to the increasing consumer demand for minimally invasive solutions that effectively reduce visible signs of aging, such as wrinkles and folds, without the downtime associated with surgical procedures. The growing availability of advanced dermal fillers with longer-lasting results, enhanced safety profiles, and natural-looking outcomes is driving patient preference for these treatments.

The Facial Line Correction segment is likely to witness accelerated growth of 10.76% during the forecast period, supported by increasing demand for non-surgical solutions to treat dynamic and static wrinkles, especially in the forehead, nasolabial folds, marionette lines, and crow’s feet areas.

• By Drug Type

On the basis of drug type, the Middle East and North Africa Aesthetic Injectable Fillers Market is segmented into branded, and generic, In 2025, the branded segment is expected to dominate with 83.99% market share, due to strong consumer trust in well-established aesthetic filler brands that have proven safety, efficacy, and consistent results over time. Leading brands such as juvederm, restylane, and radiesse benefit from extensive clinical research, Middle East & North Africa regulatory approvals, and strong brand recognition, making them the preferred choice among both practitioners and patients.

The Branded segment is gaining importance and growing with the CAGR of 9.46%, due to increasing consumer trust in well-established, clinically tested products that offer proven safety, efficacy, and consistent results.

• By End User

On the basis of end user, the Middle East and North Africa Aesthetic Injectable Fillers Market is segmented into dermatology clinics, hospitals, ambulatory surgical centers, and others. In 2025, the Dermatology Clinics segment is expected to dominate with 52.98% market share, supported by growing demand for specialized, minimally invasive aesthetic procedures performed by trained dermatologists with advanced expertise in facial anatomy and injection techniques. These clinics offer personalized treatment plans, state-of-the-art equipment, and a wide variety of filler options tailored to individual patient needs.

The Dermatology Clinics segment is expected to grow at a CAGR of 9.83%, driven by increasing consumer preference for specialist-led aesthetic procedures, rising demand for safe and personalized treatment plans, and growing trust in medical-grade skincare and injectable solutions.

• By Distribution Channel

On the basis of distribution channel, the Middle East and North Africa Aesthetic Injectable Fillers Market is segmented into direct tender/direct distribution, drug stores, online pharmacy, and others. In 2025, the direct tender/direct distribution segment is expected to dominate with 63.69% market share, owing to the large Middle East & North Africa cattle population and the critical role of trace minerals in milk production, fertility, and disease resistance.

The Direct Tender/Direct Distribution segment is anticipated to record the fastest growth of 9.59% during 2025 to 2036, driven by increasing demand for streamlined procurement processes, cost savings through elimination of intermediaries, and growing adoption of digital ordering platforms by healthcare providers and aesthetic clinics.

Middle East and North Africa Aesthetic Injectable Fillers Market – Regional Analysis

UAE is expected to dominate the Aesthetic Injectable Fillers market with the largest revenue share of 28.07% in 2025, driven by rising disposable income, increasing aesthetic awareness, and expanding access to non-invasive cosmetic procedures across key countries like UAE, Egypt, Saudi Arabia, and Israel
The region’s growth is strongly supported by demographic shifts including a rapidly aging population and increased acceptance of aesthetic treatments among younger consumers, particularly millennials and Gen Z. Social media influence, medical tourism, and cultural shifts around beauty standards are also contributing to rising procedure volumes in both urban and tier-2 cities
UAE and Egypt are among the primary growth engines within Middle East & North Africa, with UAE experiencing rapid adoption of hyaluronic acid-based fillers and anti-aging treatments, and Egypt showing a surge in botulinum toxin and dermal filler procedures due to improving healthcare infrastructure, affordability, and a growing number of certified aesthetic clinics
Regulatory advancements and improving safety standards in countries like Australia and Israel are enhancing consumer trust and market credibility, encouraging first-time users and supporting long-term market expansion. Additionally, innovations by regional players such as Bloomage Biotechnology in UAE are making the region more competitive in both manufacturing and clinical application of injectable fillers

UAE Aesthetic Injectable Fillers Market Insight

UAE accounted for the largest revenue share of 22.92% in the Middle East and North Africa Aesthetic Injectable Fillers Market in 2025, fueled by its vast population, rapid urbanization, and growing demand for anti-aging treatments. The country has become a hub for dermal fillers, particularly hyaluronic acid-based products, due to the presence of domestic manufacturers like Bloomage Biotechnology, one of the largest Middle East & North Africa producers of HA. Rising disposable incomes and changing societal attitudes toward cosmetic enhancements are normalizing the use of injectable fillers across various age groups. Government support for medical aesthetics innovation and increasing investments in research and clinical trials further enhance the country’s dominance in the regional market.

Egypt Aesthetic Injectable Fillers Market Insight

Egypt is experiencing rapid growth in the aesthetic injectable fillers market, supported by an expanding urban population, rising beauty consciousness, and increasing demand for affordable, non-surgical cosmetic treatments. The growth of dermatology and aesthetic clinics, particularly in metro and tier-2 cities, is making injectables more accessible to a broader population. Social media influence and the increasing popularity of celebrity-inspired beauty standards are key drivers of market expansion. Additionally, Egypt's medical tourism sector, known for cost-effective procedures and skilled practitioners, is contributing to rising international demand. As awareness and acceptance of minimally invasive treatments grow, the Egyptn market is expected to remain one of the fastest-growing in Middle East & North Africa.

Israel Aesthetic Injectable Fillers Market Insight

Israel is a mature and innovation-driven market for aesthetic injectables, Middle East & North Africaly recognized for its leadership in cosmetic dermatology and advanced beauty standards. High consumer demand for facial contouring and skin rejuvenation procedures has made fillers a core part of mainstream aesthetic treatments. The country's strong domestic manufacturing base, rigorous regulatory environment, and emphasis on product safety and efficacy foster continuous innovation in filler materials and techniques. Additionally, the widespread popularity of K-beauty and Korean pop culture fuels demand among both domestic and international patients, with Israel remaining a key destination for medical tourism in the aesthetics space.

Saudi Arabia Aesthetic Injectable Fillers Market Insight

Saudi Arabia represents a significant and highly regulated market for aesthetic injectables, with growing interest among aging populations seeking natural-looking, non-surgical anti-aging solutions. Cultural preferences for subtle aesthetic enhancement have driven the adoption of conservative filler techniques, particularly around the eyes and midface. The market benefits from a strong dermatological infrastructure, high standards for medical safety, and increasing awareness of advanced treatment options. Rising consumer education and availability of premium imported products—combined with favorable demographic trends—are contributing to steady growth in Saudi Arabia’s injectable filler segment.

The Major Market Leaders Operating in the Market Are:

Allergan Aesthetics (AbbVie) (United States)
GALDERMA (Switzerland)
Merz Pharma (UAE)
Hugel Inc. (Israel)
LG Chem (Israel)
Medytox Inc. (Israel)
IBSA Institut Biochimique SA (Switzerland)
Laboratoires Vivacy (France)
Prollenium Medical Technologies (Canada)
Croma (Austria)
FillMed Laboratories (France)
Humedix (Israel)
TEOXANE (Switzerland)
Sinclair (United Kingdom)
Bioscience (UAE)
Amalian (UAE)
Bioxis Pharmaceuticals (France)
Mesoestetic (Spain)
Zhejiang Jingjia Medical Technology Co., Ltd. (UAE)
Jalupro (Italy)
BIOPLUS CO. LTD. (Israel)
Shanghai Reyoungel Medical Technology Company Limited (UAE)
Contura International Ltd (United Kingdom)
Tiger Aesthetics Medical, LLC (United States)
Huons Middle East & North Africa (Israel)
Vida Srl. (Italy)
Sosum Middle East & North Africa (Israel)
Revance (United States)
Petrone Group (Italy)

Latest Developments in Middle East and North Africa Aesthetic Injectable Fillers Market

In January 2025, Allergan Aesthetics announced the return of CoolMonth, a promotional campaign offering special deals on CoolSculpting Elite treatments. This initiative aims to increase patient access to the non-invasive fat reduction procedure by providing discounted pricing during the campaign period, encouraging wider adoption and enhancing patient engagement in aesthetic body contouring.
In April 2025, Galderma announced the launch of Sculptra in UAE, a key move to capitalize on one of the world's fastest-growing aesthetics markets. Sculptra, a regenerative biostimulator with a unique poly-L-lactic acid (PLLA-SCA) formulation, was approved by UAE's National Medical Products Administration for correcting mid-facial volume loss and/or contour deficiencies.
This launch gives Chinese patients and healthcare professionals access to a premium product with over 25 years of clinical evidence. The aesthetics market in UAE has been expanding rapidly, and the introduction of Sculptra positions Galderma to meet the increasing consumer demand for safe, natural-looking, and long-lasting treatments.
In May 2025, Hugel, launched its botulinum toxin product, Botulax, in the United Arab Emirates (UAE). Hugel is partnering with the local company Medica Group to sell and distribute the product. With the UAE being a central hub for the beauty industry and the region's demand for aesthetic treatments on the rise, Hugel is hoping to quickly gain a strong foothold in this new market with its high-quality product.
In February 2025, LG Chem accelerated commercial production of its 100% plant-based acrylic acid, marking a key innovation in sustainable chemical manufacturing. This development aligns with Middle East & North Africa demand for eco-friendly materials and reduces reliance on fossil resources. It enhances LG Chem’s position in the bio-based plastics and polymer market, supporting its strategy for a net-zero future and leadership in green chemistry solutions.
In March 2024, Croma’s affiliate in Brazil was acquired by Megalabs, which also secured exclusive distribution rights for Croma’s aesthetic product portfolio across Latin America and the Caribbean. The portfolio includes hyaluronic acid fillers, polynucleotide injectables, skincare products, and upcoming technologies. This partnership enables Croma to expand into a key growth market while allowing Megalabs to strengthen its presence in dermatology and aesthetic medicine with premium offerings

SKU-74701

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET END USER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PORTER’S FIVE FORCES

4.1.1 COMPETITIVE RIVALRY – HIGH

4.1.2 THREAT OF NEW ENTRANTS – MODERATE

4.1.3 BARGAINING POWER OF BUYERS – HIGH

4.1.4 BARGAINING POWER OF SUPPLIERS – MODERATE

4.1.5 THREAT OF SUBSTITUTES – MODERATE

4.2 PESTLE ANALYSIS

4.2.1 POLITICAL

4.2.2 ECONOMIC

4.2.3 SOCIAL

4.2.4 TECHNOLOGICAL

4.2.5 ENVIRONMENTAL

4.2.6 LEGAL

4.3 COST ANALYSIS BREAKDOWN

4.3.1 RESEARCH & DEVELOPMENT (R&D) COSTS (15–25%)

4.3.2 RAW MATERIAL AND COMPONENT COSTS (20–30%)

4.3.3 MANUFACTURING COSTS (15–20%)

4.3.4 REGULATORY & QUALITY COMPLIANCE (5–10%)

4.3.5 MARKETING & PROMOTION (10–15%)

4.3.6 DISTRIBUTION & LOGISTICS (5–10%)

4.3.7 LICENSING, ROYALTIES & IP MANAGEMENT (1–3%)

4.3.8 TRAINING, CLINICAL SUPPORT & AFTER-SALES (2–5%)

4.4 HEALTHCARE ECONOMY

4.4.1 HEALTHCARE EXPENDITURE

4.4.2 CAPITAL EXPENDITURE

4.4.3 CAPEX TRENDS

4.4.4 CAPEX ALLOCATION

4.4.5 FUNDING SOURCES

4.4.6 INDUSTRY BENCHMARKS

4.4.7 GDP RATIO IN OVERALL GDP

4.4.8 HEALTHCARE SYSTEM STRUCTURE

4.4.9 GOVERNMENT POLICIES

4.4.10 ECONOMIC DEVELOPMENT

4.5 OPPORTUNITY MAP ANALYSIS

4.5.1 OPPORTUNITY MAP ANALYSIS

4.5.2 PRODUCT INNOVATION

4.5.3 GEOGRAPHIC EXPANSION

4.5.4 CONSUMER SEGMENTATION

4.5.5 DELIVERY CHANNELS

4.5.6 REGULATORY & MARKET ACCESS

4.5.7 SUSTAINABILITY

4.6 INDUSTRY INSIGHTS

4.6.1 MICRO AND MACRO ECONOMIC FACTORS

4.6.2 PENETRATION AND GROWTH PROSPECT MAPPING

4.6.3 KEY PRICING STRATEGIES

4.6.4 INTERVIEWS WITH SPECIALISTS

4.6.5 ANALYSIS AND RECOMMENDATION

4.7 PATENT ANALYSIS-

4.7.1 GEOGRAPHIC DISTRIBUTION OF PATENT FILINGS

4.7.2 KEY APPLICANTS AND INNOVATORS

4.7.3 TECHNOLOGICAL DOMAINS (IPC CODES)

4.8 PUBLICATION TRENDS OVER TIME

4.8.1 CONCLUSION

4.9 EIMBURSEMENT FRAMEWORK

4.9.1 COSMETIC VS. MEDICAL USE – THE CORE DIVIDER

4.9.2 REGIONAL REIMBURSEMENT VARIATIONS

4.9.3 OUT-OF-POCKET SPENDING DOMINANCE

4.9.4 TRENDS IN HYBRID INSURANCE MODELS

4.9.5 IMPLICATIONS FOR MARKET GROWTH

4.1 SUPPLY CHAIN ECOSYSTEM

4.11 TECHNOLOGY ROADMAP

4.12 INNOVATION TRACKER AND STRATEGIC ANALYSIS

4.12.1 INNOVATION TRACKER

4.12.1.1 Bio-Remodeling & Platform Technologies

4.12.1.2 Smart Filler Design & Volume Efficiency

4.12.1.3 Next-Generation Delivery Systems

4.12.1.4 Green Chemistry and Bioplastics

4.12.1.5 Combination Modalities

4.12.2 STRATEGIC ANALYSIS

4.12.2.1 M&A and Market Consolidation

4.12.2.2 Geographical Expansion & Localization Strategies

4.12.2.3 Regulatory Milestones

4.12.2.4 Marketing & Consumer Engagement

4.12.2.5 Strategic Partnerships & Distribution Rights

4.12.3 CONCLUSION

5 CURRENT TARIFF RATES IN TOP-5 COUNTRY MARKETS AND IMPORT VS. LOCAL PRODUCTION OUTLOOK

5.1 VENDOR SELECTION CRITERIA AND ITS IMPACT ON THE SUPPLY CHAIN

5.2 RAW MATERIAL PROCUREMENT, MANUFACTURING, AND DISTRIBUTION DYNAMICS

5.3 PRICE PITCHING AND COMPETITIVE POSITIONING IN THE MARKET

5.4 INDUSTRY RESPONSE: SUPPLY CHAIN OPTIMIZATION AND JOINT VENTURES

5.5 IMPACT OF REGULATORY FRAMEWORKS AND INCENTIVES ON PRICES

5.6 GEOPOLITICAL FACTORS AND TRADE AGREEMENTS SHAPING THE MARKET

5.7 INDUSTRIAL DEVELOPMENT SCHEMES AND INFRASTRUCTURE INITIATIVES

6 REGULATORY FRAMEWORK

6.1 NORTH AMERICA

6.1.1 REGULATORY AUTHORITIES:

6.1.2 REGULATORY CLASSIFICATIONS:

6.1.3 REGULATORY SUBMISSIONS:

6.1.4 INTERNATIONAL HARMONIZATION:

6.1.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:

6.2 SOUTH AMERICA

6.2.1 REGULATORY AUTHORITIES:

6.2.2 REGULATORY CLASSIFICATIONS:

6.2.3 REGULATORY SUBMISSIONS:

6.2.4 INTERNATIONAL HARMONIZATION:

6.2.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:

6.2.6 REGULATORY CHALLENGES AND STRATEGIES:

6.3 EUROPE

6.3.1 REGULATORY AUTHORITIES:

6.3.2 REGULATORY CLASSIFICATIONS:

6.3.3 REGULATORY SUBMISSIONS:

6.3.4 INTERNATIONAL HARMONIZATION:

6.3.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:

6.3.6 REGULATORY CHALLENGES AND STRATEGIES:

6.4 ASIA-PACIFIC

6.4.1 REGULATORY AUTHORITIES:

6.4.2 REGULATORY CLASSIFICATIONS:

6.4.3 REGULATORY SUBMISSIONS:

6.4.4 INTERNATIONAL HARMONIZATION:

6.4.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:

6.4.6 REGULATORY CHALLENGES AND STRATEGIES:

6.5 MIDDLE EAST AND AFRICA

6.5.1 REGULATORY AUTHORITIES:

6.5.2 REGULATORY CLASSIFICATIONS:

6.5.3 REGULATORY SUBMISSIONS:

6.5.4 INTERNATIONAL HARMONIZATION:

6.5.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS:

6.5.6 REGULATORY CHALLENGES AND STRATEGIES:

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 GROWING DEMAND FOR MINIMALLY INVASIVE COSMETIC PROCEDURES

7.1.2 RISING INFLUENCE OF SOCIAL MEDIA AND CELEBRITY CULTURE

7.1.3 INCREASING ACCEPTANCE OF COSMETIC ENHANCEMENTS AMONG MILLENNIALS AND GEN Z

7.1.4 RISING POPULARITY OF COMBINATION TREATMENTS

7.2 RESTRAINTS

7.2.1 HIGH COST OF AESTHETIC INJECTABLE PROCEDURES

7.2.2 SHORT-TERM EFFECTIVENESS OF CERTAIN FILLERS

7.3 OPPORTUNITIES

7.3.1 EXPANSION IN EMERGING MARKETS

7.3.2 PRODUCT INNOVATION AND PERSONALIZED SOLUTIONS

7.3.3 BROADENING INTO ADDITIONAL THERAPEUTIC AREAS

7.4 CHALLENGES

7.4.1 LACK OF SKILLED PROFESSIONALS IN CERTAIN REGIONS

7.4.2 COUNTERFEIT AND UNREGULATED PRODUCTS

8 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE

8.1 OVERVIEW

8.2 BIODEGRADABLE AESTHETIC INJECTABLE FILLERS

8.2.1 TEMPORARY BIODEGRADABLE

8.2.2 SEMI-PERMANENT BIODEGRADABLE

8.3 NON-BIODEGRADABLE AESTHETIC INJECTABLE FILLERS

9 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE

9.1 OVERVIEW

9.2 NATURAL AESTHETIC INJECTABLE FILLERS

9.2.1 HYALURONIC ACID (HA)

9.2.1.1 MONOPHASIC FILLERS

9.2.1.1.1 HYALURONIC ACID + LIDOCAINE

9.2.1.1.2 MONODENSIFIED

9.2.1.1.3 POLYDENSIFIES

9.2.1.1.4 FACIAL LINE CORRECTION

9.2.1.1.5 LIP ENHANCEMENT

9.2.1.1.6 FACE LIFT

9.2.1.1.7 RHINOPLASTY

9.2.1.1.8 SCAR TREATMENT

9.2.1.1.9 SAGGING SKIN

9.2.1.1.10 CHEEK DEPRESSION

9.2.1.1.11 DENTISTRY

9.2.1.1.12 RECONSTRUCTIVE SURGERY

9.2.1.1.13 AESTHETIC RESTORATION

9.2.1.1.14 CHIN AUGMENTATION

9.2.1.1.15 LIPOATROPHY TREATMENT

9.2.1.1.16 SKIN SMOOTHING

9.2.1.1.17 EARLOBE REJUVENATION

9.2.1.1.18 OTHERS.

9.2.1.2 BIPHASIC FILLERS

9.2.1.2.1 HYALURONIC ACID + LIDOCAINE

9.2.1.2.2 SINGLE-PHASE

9.2.1.2.3 DUPLEX-PHASE

9.2.1.2.4 FACIAL LINE CORRECTION

9.2.1.2.5 LIP ENHANCEMENT

9.2.1.2.6 FACE LIFT

9.2.1.2.7 RHINOPLASTY

9.2.1.2.8 SCAR TREATMENT

9.2.1.2.9 SAGGING SKIN

9.2.1.2.10 CHEEK DEPRESSION

9.2.1.2.11 DENTISTRY

9.2.1.2.12 RECONSTRUCTIVE SURGERY

9.2.1.2.13 AESTHETIC RESTORATION

9.2.1.2.14 CHIN AUGMENTATION

9.2.1.2.15 LIPOATROPHY TREATMENT

9.2.1.2.16 SKIN SMOOTHING

9.2.1.2.17 EARLOBE REJUVENATION

9.2.1.2.18 OTHERS

9.2.2 FAT

9.2.2.1 FACIAL LINE CORRECTION

9.2.2.2 LIP ENHANCEMENT

9.2.2.3 FACE LIFT

9.2.2.4 RHINOPLASTY

9.2.2.5 SCAR TREATMENT

9.2.2.6 SAGGING SKIN

9.2.2.7 CHEEK DEPRESSION

9.2.2.8 RECONSTRUCTIVE SURGERY

9.2.2.9 DENTISTRY

9.2.2.10 AESTHETIC RESTORATION

9.2.2.11 LIPOATROPHY TREATMENT

9.2.2.12 CHIN AUGMENTATION

9.2.2.13 SKIN SMOOTHING

9.2.2.14 EARLOBE REJUVENATION

9.2.2.15 OTHERS

9.2.3 COLLAGEN

9.2.3.1 FACIAL LINE CORRECTION

9.2.3.2 LIP ENHANCEMENT

9.2.3.3 FACE LIFT

9.2.3.4 RHINOPLASTY

9.2.3.5 SCAR TREATMENT

9.2.3.6 SAGGING SKIN

9.2.3.7 CHEEK DEPRESSION

9.2.3.8 RECONSTRUCTIVE SURGERY

9.2.3.9 AESTHETIC RESTORATION

9.2.3.10 CHIN AUGMENTATION

9.2.3.11 DENTISTRY

9.2.3.12 LIPOATROPHY TREATMENT

9.2.3.13 SKIN SMOOTHING

9.2.3.14 EARLOBE REJUVENATION

9.2.3.15 OTHERS

9.2.4 POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN)

9.2.4.1 FACIAL LINE CORRECTION

9.2.4.2 LIP ENHANCEMENT

9.2.4.3 FACE LIFT

9.2.4.4 RHINOPLASTY

9.2.4.5 SCAR TREATMENT

9.2.4.6 SAGGING SKIN

9.2.4.7 CHEEK DEPRESSION

9.2.4.8 AESTHETIC RESTORATION

9.2.4.9 RECONSTRUCTIVE SURGERY

9.2.4.10 DENTISTRY

9.2.4.11 CHIN AUGMENTATION

9.2.4.12 LIPOATROPHY TREATMENT

9.2.4.13 SKIN SMOOTHING

9.2.4.14 EARLOBE REJUVENATION

9.2.4.15 OTHERS

9.2.5 OTHERS

9.2.5.1 FACIAL LINE CORRECTION

9.2.5.2 LIP ENHANCEMENT

9.2.5.3 FACE LIFT

9.2.5.4 RHINOPLASTY

9.2.5.5 SCAR TREATMENT

9.2.5.6 SAGGING SKIN

9.2.5.7 CHEEK DEPRESSION

9.2.5.8 RECONSTRUCTIVE SURGERY

9.2.5.9 AESTHETIC RESTORATION

9.2.5.10 DENTISTRY

9.2.5.11 CHIN AUGMENTATION

9.2.5.12 LIPOATROPHY TREATMENT

9.2.5.13 SKIN SMOOTHING

9.2.5.14 EARLOBE REJUVENATION

9.2.5.15 OTHERS

9.3 SYNTHETIC AESTHETIC INJECTABLE FILLERS

9.3.1 CALCIUM HYDROXYLAPATITE (CAHA)

9.3.1.1 FACIAL LINE CORRECTION

9.3.1.2 LIP ENHANCEMENT

9.3.1.3 FACE LIFT

9.3.1.4 RHINOPLASTY

9.3.1.5 SCAR TREATMENT

9.3.1.6 SAGGING SKIN

9.3.1.7 CHEEK DEPRESSION

9.3.1.8 RECONSTRUCTIVE SURGERY

9.3.1.9 AESTHETIC RESTORATION

9.3.1.10 DENTISTRY

9.3.1.11 CHIN AUGMENTATION

9.3.1.12 LIPOATROPHY TREATMENT

9.3.1.13 SKIN SMOOTHING

9.3.1.14 EARLOBE REJUVENATION

9.3.1.15 OTHERS

9.3.2 POLY-L-LACTIC ACID (PLLA)

9.3.2.1 FACIAL LINE CORRECTION

9.3.2.2 LIP ENHANCEMENT

9.3.2.3 FACE LIFT

9.3.2.4 RHINOPLASTY

9.3.2.5 SCAR TREATMENT

9.3.2.6 SAGGING SKIN

9.3.2.7 CHEEK DEPRESSION

9.3.2.8 RECONSTRUCTIVE SURGERY

9.3.2.9 AESTHETIC RESTORATION

9.3.2.10 DENTISTRY

9.3.2.11 CHIN AUGMENTATION

9.3.2.12 LIPOATROPHY TREATMENT

9.3.2.13 SKIN SMOOTHING

9.3.2.14 EARLOBE REJUVENATION

9.3.2.15 OTHERS

9.3.3 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)

9.3.3.1 FACIAL LINE CORRECTION

9.3.3.2 LIP ENHANCEMENT

9.3.3.3 FACE LIFT

9.3.3.4 RHINOPLASTY

9.3.3.5 SCAR TREATMENT

9.3.3.6 SAGGING SKIN

9.3.3.7 CHEEK DEPRESSION

9.3.3.8 RECONSTRUCTIVE SURGERY

9.3.3.9 AESTHETIC RESTORATION

9.3.3.10 DENTISTRY

9.3.3.11 CHIN AUGMENTATION

9.3.3.12 LIPOATROPHY TREATMENT

9.3.3.13 SKIN SMOOTHING

9.3.3.14 EARLOBE REJUVENATION

9.3.3.15 OTHERS

10 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE

10.1 OVERVIEW

10.2 BRANDED

10.2.1 JUVEDERM

10.2.2 RESTYLANE

10.2.3 RADIESSE

10.2.4 SCULPTRA

10.2.5 ELLANSE

10.2.6 BELLAFILL

10.2.7 AQUAMID

10.2.8 ELEVESS

10.2.9 OTHERS

10.3 GENERIC

11 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION

11.1 OVERVIEW

11.2 FACIAL LINE CORRECTION

11.2.1 DYNAMIC WRINKLES

11.2.2 STATIC WRINKLES

11.2.3 WRINKLE FOLDS

11.2.4 LAUGH LINES

11.2.5 FOREHEAD LINES

11.2.6 WORRY LINES

11.2.7 CROW’S FEET

11.2.8 LIP LINES

11.2.9 MARIONETTE LINES

11.2.10 PUPPET WRINKLES

11.2.11 BUNNY LINES

11.2.12 OTHERS

11.2.13 JUVEDERM

11.2.14 RESTYLANE

11.2.15 BELOTERO

11.2.16 RADIESSE

11.2.17 OTHERS

11.3 LIP ENHANCEMENT

11.3.1 JUVÉDERM

11.3.1.1 JUVÉDERM XC

11.3.1.2 VOLUMA

11.3.1.3 VOLBELLA

11.3.1.4 VOLLURE

11.3.2 RESTYLANE

11.3.2.1 RESTYLANE LYFT

11.3.2.2 RESTYLANE KYSSE

11.3.2.3 RESTYLANE CONTOUR

11.3.2.4 RESTYLANE REFYNE

11.3.2.5 RESTYLANE SILK

11.3.3 BELOTERO BALANCE

11.3.4 RHA

11.3.4.1 RHA 2

11.3.4.2 RHA 3

11.3.4.3 RHA 4

11.3.5 REVANESSE VERSA

11.3.6 HYLAFORM

11.3.7 ELEVESS

11.3.8 PREVELLE SILK

11.3.9 OTHERS

11.4 FACE LIFT

11.4.1 DEEP PLANE/SMAS FACELIFT

11.4.2 MINI FACELIFT

11.4.3 MID-FACELIFT

11.4.4 LIQUID FACELIFT

11.4.5 CHEEK LIFT

11.4.6 JAW LINE REJUVENATION

11.4.7 S-LIFT

11.4.8 CUTANEOUS LIFT

11.4.9 TEMPORAL/BROW LIFT

11.4.10 OTHERS

11.4.11 JUVEDERM

11.4.12 RESTYLANE

11.4.13 SCULPTRA

11.4.14 DYSPORT

11.4.15 OTHERS

11.5 RHINOPLASTY

11.5.1 JUVÉDERM

11.5.1.1 VOLUMA

11.5.1.2 VOLBELLA

11.5.1.3 JUVÉDERM XC

11.5.1.4 VOLLURE

11.5.2 RESTYLANE

11.5.2.1 RESTYLANE LYFT

11.5.2.2 RESTYLANE SILK

11.5.2.3 RESTYLANE REFYNE

11.5.2.4 RESTYLANE KYSSE

11.5.2.5 RESTYLANE CONTOUR

11.5.3 BELOTERO BALANCE

11.5.4 REVANESSE VERSA

11.5.5 RHA

11.5.5.1 RHA 2

11.5.5.2 RHA 3

11.5.5.3 RHA 4

11.5.6 HYLAFORM

11.5.7 ELEVESS

11.5.8 PREVELLE SILK

11.5.9 OTHERS

11.6 SCAR TREATMENT

11.6.1 ACNE SCARS

11.6.2 HYPERTROPHIC SCARS

11.6.3 KELOID SCARS

11.6.4 CONTRACTURE SCARS

11.6.5 OTHERS

11.6.6 JUVEDERM

11.6.7 RESTYLANE

11.6.8 RADIESSE

11.6.9 BELOTERO

11.6.10 PERLANE

11.6.11 OTHERS

11.7 SAGGING SKIN

11.7.1 BOLETERO

11.7.2 RESTYLANE

11.7.3 JUVEDERM

11.7.4 OTHERS

11.8 CHEEK DEPRESSION

11.8.1 JUVEDERM VOLUMA

11.8.2 RESTYLANE-LYFT

11.8.3 SCULPTRA

11.8.4 RADIESSE

11.8.5 OTHERS

11.9 RECONSTRUCTIVE SURGERY

11.9.1 JUVEDERM

11.9.2 RESTYLANE

11.9.3 OTHERS

11.1 AESTHETIC RESTORATION

11.10.1 JUVÉDERM

11.10.1.1 JUVEDERM ULTRA XC

11.10.1.2 JUVEDERM VOLBELLA XC

11.10.1.3 JUVEDERM VOLLURE XC

11.10.2 RESTYLANE

11.10.2.1 RESTYLANE LYFT

11.10.2.2 RESTYLANE-L

11.10.2.3 RESTYLANE REFYNE AND DEFYNE

11.10.2.4 RESTYLANE SILK

11.10.3 SCULPTRA

11.10.4 RADIESSE

11.10.5 RHA

11.10.5.1 RHA 2

11.10.5.2 RHA 3

11.10.5.3 RHA 4

11.10.6 REVANESSE VERSA

11.10.7 BELOTERO BALANCE

11.10.8 BELLAFILL

11.10.9 OTHERS

11.11 DENTISTRY

11.11.1 JUVEDERM

11.11.2 RESTYLANE

11.11.3 RADIESSE

11.11.4 OTHERS

11.12 CHIN AUGMENTATION

11.12.1 JUVEDERM VOLUMA XC

11.12.2 RESTYLANE DEFYNE

11.12.3 OTHERS

11.13 LIPOATROPHY TREATMENT

11.13.1 SCULPTRA

11.13.2 OTHERS

11.14 SKIN SMOOTHING

11.14.1 RESTYLANE

11.14.2 BELOTERO

11.14.3 BELLAFIL

11.14.4 OTHERS

11.15 EARLOBE REJUVENATION

11.15.1 SCULPTRA

11.15.2 RESTYLANE

11.15.3 ELLANSÉ

11.15.4 BELOTERO

11.15.5 JUVEDERM

11.15.6 OTHERS

11.16 OTHERS

12 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY END USER

12.1 OVERVIEW

12.2 DERMATOLOGY CLINICS

12.3 HOSPITALS

12.4 AMBULATORY SURGICAL CENTERS

12.5 OTHERS

13 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER/DIRECT DISTRIBUTION

13.3 DRUG STORES

13.4 ONLINE PHARMACY

13.5 OTHERS

14 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY REGION

14.1 MIDDLE EAST AND NORTH AFRICA

14.1.1 U.A.E.

14.1.2 SAUDI ARABIA

14.1.3 EGYPT

14.1.4 ISRAEL

14.1.5 BAHRAIN

14.1.6 TURKEY

14.1.7 KUWAIT

14.1.8 OMAN

14.1.9 REST OF MIDDLE EAST & NORTH AFRICA

15 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: COMPANY LANDSCAPE

15.1 COMPANY SHARE ANALYSIS: MEA

16 SWOT ANALYSIS

17 COMPANY PROFILE

17.1 ALLERGAN AESTHETICS

17.1.1 COMPANY SNAPSHOTS

17.1.2 REVENUE ANALYSIS AND SEGMENTED ANALYSIS

17.1.3 COMPANY SHARE ANALYSIS

17.1.4 PRODUCT PORTFOLIO

17.1.5 RECENT DEVELOPMENT

17.2 GALDERMA

17.2.1 COMPANY SNAPSHOT

17.2.2 REVENUE ANALYSIS

17.2.3 COMPANY SHARE ANALYSIS

17.2.4 PRODUCT PORTFOLIO

17.2.5 RECENT DEVELOPMENT

17.3 MERZ PHARMA

17.3.1 COMPANY SNAPSHOT

17.3.2 COMPANY SHARE ANALYSIS

17.3.3 PRODUCT PORTFOLIO

17.3.4 RECENT DEVELOPMENT

17.4 HUGEL, INC.

17.4.1 COMPANY SNAPSHOT

17.4.2 REVENUE ANALYSIS

17.4.3 COMPANY SHARE ANALYSIS

17.4.4 PRODUCT PORTFOLIO

17.4.5 RECENT DEVELOPMENT

17.5 LG CHEM

17.5.1 COMPANY SNAPSHOT

17.5.2 REVENUE ANALYSIS

17.5.3 COMPANY SHARE ANALYSIS

17.5.4 PRODUCT PORTFOLIO

17.5.5 RECENT DEVELOPMENT

17.6 AMALIAN

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENT

17.7 BIOSCIENCE

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENT

17.8 BIOPLUS CO. LTD.

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENT

17.9 BIOXIS PHARMACEUTICALS

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENT

17.1 CONTURA INTERNATIONAL LTD

17.10.1 COMPANY SNAPSHOT

17.10.2 PRODUCT PORTFOLIO

17.10.3 RECENT DEVELOPMENT

17.11 CROMA-PHARMA GMBH

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 HUONS GLOBAL

17.12.1 COMPANY SNAPSHOT

17.12.2 REVENUE ANALYSIS

17.12.3 PRODUCT PORTFOLIO

17.12.4 RECENT DEVELOPMENT

17.13 HUMEDIX

17.13.1 COMPANY SNAPSHOT

17.13.2 REVENUE ANALYSIS

17.13.3 PRODUCT PORTFOLIO

17.13.4 RECENT DEVELOPMENT

17.14 IBSA INSTITUT BIOCHIMIQUE SA

17.14.1 COMPANY SNAPSHOT

17.14.2 PRODUCT PORTFOLIO

17.14.3 RECENT DEVELOPMENT

17.15 JALUPRO

17.15.1 COMPANY SNAPSHOT

17.15.2 PRODUCT PORTFOLIO

17.15.3 RECENT DEVELOPMENT

17.16 LABORATORIES VIVACY

17.16.1 COMPANY SNAPSHOT

17.16.2 PRODUCT PORTFOLIO

17.16.3 RECENT DEVELOPMENT

17.17 LABORATORIES FILLMED

17.17.1 COMPANY SNAPSHOT

17.17.2 PRODUCT PORTFOLIO

17.17.3 RECENT DEVELOPMENT

17.18 MEDYTOX INC

17.18.1 COMPANY SNAPSHOT

17.18.2 REVENUE ANALYSIS

17.18.3 PRODUCT PORTFOLIO

17.18.4 RECENT DEVELOPMENT

17.19 MESOESTETIC

17.19.1 COMPANY SNAPSHOT

17.19.2 PRODUCT PORTFOLIO

17.19.3 RECENT DEVELOPMENT

17.2 PETRONE GROUP

17.20.1 COMPANY SNAPSHOT

17.20.2 PRODUCT PORTFOLIO

17.20.3 RECENT DEVELOPMENT

17.21 PREMIER MEDICAL GROUP

17.21.1 COMPANY SNAPSHOT

17.21.2 PRODUCT PORTFOLIO

17.21.3 RECENT DEVELOPMENT

17.22 PROLLENIUM MEDICAL TECHNOLOGIES

17.22.1 COMPANY SNAPSHOT

17.22.2 PRODUCT PORTFOLIO

17.22.3 RECENT DEVELOPMENT

17.23 REVANCE

17.23.1 COMPANY SNAPSHOT

17.23.2 PRODUCT PORTFOLIO

17.23.3 RECENT DEVELOPMENT

17.24 SINCLAIR

17.24.1 COMPANY SNAPSHOT

17.24.2 PRODUCT PORTFOLIO

17.24.3 RECENT DEVELOPMENT

17.25 SHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED

17.25.1 COMPANY SNAPSHOT

17.25.2 PRODUCT PORTFOLIO

17.25.3 RECENT DEVELOPMENT

17.26 SOSUM GLOBAL

17.26.1 COMPANY SNAPSHOT

17.26.2 PRODUCT PORTFOLIO

17.26.3 RECENT DEVELOPMENT

17.27 TIGER AESTHETICS MEDICAL, LLC

17.27.1 COMPANY SNAPSHOT

17.27.2 PRODUCT PORTFOLIO

17.27.3 RECENT DEVELOPMENT

17.28 TEOXANE

17.28.1 COMPANY SNAPSHOT

17.28.2 PRODUCT PORTFOLIO

17.28.3 RECENT DEVELOPMENT

17.29 VIDA SRL.

17.29.1 COMPANY SNAPSHOT

17.29.2 PRODUCT PORTFOLIO

17.29.3 RECENT DEVELOPMENT

17.3 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO., LTD.

17.30.1 COMPANY SNAPSHOT

17.30.2 PRODUCT PORTFOLIO

17.30.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

List of Table

TABLE 1 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 2 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 3 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 4 MIDDLE EAST AND AFRICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 5 MIDDLE EAST AND AFRICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 6 MIDDLE EAST AND AFRICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 7 MIDDLE EAST AND AFRICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 8 MIDDLE EAST AND AFRICA NON-BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 9 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 10 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 11 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 12 MIDDLE EAST AND AFRICA NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 13 MIDDLE EAST AND AFRICA NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 14 MIDDLE EAST AND AFRICA HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 15 MIDDLE EAST AND AFRICA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 16 MIDDLE EAST AND AFRICA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 17 MIDDLE EAST AND AFRICA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 18 MIDDLE EAST AND AFRICA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 19 MIDDLE EAST AND AFRICA FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 20 MIDDLE EAST AND AFRICA COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 21 MIDDLE EAST AND AFRICA POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 22 MIDDLE EAST AND AFRICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 23 MIDDLE EAST AND AFRICA SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 24 MIDDLE EAST AND AFRICA SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 25 MIDDLE EAST AND AFRICA CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 26 MIDDLE EAST AND AFRICA POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 27 MIDDLE EAST AND AFRICA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 28 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 29 MIDDLE EAST AND AFRICA BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 30 MIDDLE EAST AND AFRICA BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 31 MIDDLE EAST AND AFRICA GENERIC IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 32 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 33 MIDDLE EAST AND AFRICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 34 MIDDLE EAST AND AFRICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 35 MIDDLE EAST AND AFRICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 36 MIDDLE EAST AND AFRICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 37 MIDDLE EAST AND AFRICA LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 38 MIDDLE EAST AND AFRICA LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 39 MIDDLE EAST AND AFRICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 40 MIDDLE EAST AND AFRICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 41 MIDDLE EAST AND AFRICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 42 MIDDLE EAST AND AFRICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 43 MIDDLE EAST AND AFRICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 44 MIDDLE EAST AND AFRICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 45 MIDDLE EAST AND AFRICA RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 46 MIDDLE EAST AND AFRICA RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 47 MIDDLE EAST AND AFRICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 48 MIDDLE EAST AND AFRICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 49 MIDDLE EAST AND AFRICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 50 MIDDLE EAST AND AFRICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 51 MIDDLE EAST AND AFRICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 52 MIDDLE EAST AND AFRICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 53 MIDDLE EAST AND AFRICA SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 54 MIDDLE EAST AND AFRICA SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 55 MIDDLE EAST AND AFRICA CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 56 MIDDLE EAST AND AFRICA CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 57 MIDDLE EAST AND AFRICA RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 58 MIDDLE EAST AND AFRICA RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 59 MIDDLE EAST AND AFRICA AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 60 MIDDLE EAST AND AFRICA AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 61 MIDDLE EAST AND AFRICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 62 MIDDLE EAST AND AFRICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 63 MIDDLE EAST AND AFRICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 64 MIDDLE EAST AND AFRICA DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 65 MIDDLE EAST AND AFRICA DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 66 MIDDLE EAST AND AFRICA CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 67 MIDDLE EAST AND AFRICA CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 68 MIDDLE EAST AND AFRICA LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 69 MIDDLE EAST AND AFRICA LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 70 MIDDLE EAST AND AFRICA SKIN SMOOTHING IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 71 MIDDLE EAST AND AFRICA SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 72 MIDDLE EAST AND AFRICA EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 73 MIDDLE EAST AND AFRICA EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 74 MIDDLE EAST AND AFRICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 75 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 76 MIDDLE EAST AND AFRICA DERMATOLOGY CLINICS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 77 MIDDLE EAST AND AFRICA HOSPITALS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 78 MIDDLE EAST AND AFRICA AMBULATORY SURGICAL CENTERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 79 MIDDLE EAST AND AFRICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 80 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 81 MIDDLE EAST AND AFRICA DIRECT TENDER/DIRECT DISTRIBUTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 82 MIDDLE EAST AND AFRICA DRUG STORES IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 83 MIDDLE EAST AND AFRICA ONLINE PHARMACY IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 84 MIDDLE EAST AND AFRICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY REGION, 2018-2036 (USD THOUSAND)

TABLE 85 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY COUNTRY, 2018-2036 (USD THOUSAND)

TABLE 86 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 87 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 88 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 89 MIDDLE EAST & NORTH AFRICA NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 90 MIDDLE EAST & NORTH AFRICA HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 91 MIDDLE EAST & NORTH AFRICA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 92 MIDDLE EAST & NORTH AFRICA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 93 MIDDLE EAST & NORTH AFRICA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 94 MIDDLE EAST & NORTH AFRICA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 95 MIDDLE EAST & NORTH AFRICA FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 96 MIDDLE EAST & NORTH AFRICA COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 97 MIDDLE EAST & NORTH AFRICA POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 98 MIDDLE EAST & NORTH AFRICA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 99 MIDDLE EAST & NORTH AFRICA SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 100 MIDDLE EAST & NORTH AFRICA CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 101 MIDDLE EAST & NORTH AFRICA POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 102 MIDDLE EAST & NORTH AFRICA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 103 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 104 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 105 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 106 MIDDLE EAST & NORTH AFRICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 107 MIDDLE EAST & NORTH AFRICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 108 MIDDLE EAST & NORTH AFRICA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 109 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 110 MIDDLE EAST & NORTH AFRICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 111 MIDDLE EAST & NORTH AFRICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 112 MIDDLE EAST & NORTH AFRICA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 113 MIDDLE EAST & NORTH AFRICA LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 114 MIDDLE EAST & NORTH AFRICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 115 MIDDLE EAST & NORTH AFRICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 116 MIDDLE EAST & NORTH AFRICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 117 MIDDLE EAST & NORTH AFRICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 118 MIDDLE EAST & NORTH AFRICA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 119 MIDDLE EAST & NORTH AFRICA RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 120 MIDDLE EAST & NORTH AFRICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 121 MIDDLE EAST & NORTH AFRICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 122 MIDDLE EAST & NORTH AFRICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 123 MIDDLE EAST & NORTH AFRICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 124 MIDDLE EAST & NORTH AFRICA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 125 MIDDLE EAST & NORTH AFRICA SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 126 MIDDLE EAST & NORTH AFRICA CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 127 MIDDLE EAST & NORTH AFRICA RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 128 MIDDLE EAST & NORTH AFRICA AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 129 MIDDLE EAST & NORTH AFRICA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 130 MIDDLE EAST & NORTH AFRICA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 131 MIDDLE EAST & NORTH AFRICA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 132 MIDDLE EAST & NORTH AFRICA DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 133 MIDDLE EAST & NORTH AFRICA CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 134 MIDDLE EAST & NORTH AFRICA LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 135 MIDDLE EAST & NORTH AFRICA SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 136 MIDDLE EAST & NORTH AFRICA EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 137 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 138 MIDDLE EAST & NORTH AFRICA BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 139 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 140 MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 141 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 142 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 143 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 144 U.A.E. NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 145 U.A.E. HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 146 U.A.E. MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 147 U.A.E. MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 148 U.A.E. BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 149 U.A.E. BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 150 U.A.E. FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 151 U.A.E. COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 152 U.A.E. POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 153 U.A.E. OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 154 U.A.E. SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 155 U.A.E. CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 156 U.A.E. POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 157 U.A.E. POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 158 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 159 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 160 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 161 U.A.E. BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 162 U.A.E. BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 163 U.A.E. BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 164 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 165 U.A.E. FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 166 U.A.E. FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 167 U.A.E. FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 168 U.A.E. LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 169 U.A.E. JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 170 U.A.E. RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 171 U.A.E. RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 172 U.A.E. FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 173 U.A.E. FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 174 U.A.E. RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 175 U.A.E. JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 176 U.A.E. RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 177 U.A.E. RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 178 U.A.E. SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 179 U.A.E. SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 180 U.A.E. SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 181 U.A.E. CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 182 U.A.E. RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 183 U.A.E. AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 184 U.A.E. JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 185 U.A.E. RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 186 U.A.E. RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 187 U.A.E. DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 188 U.A.E. CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 189 U.A.E. LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 190 U.A.E. SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 191 U.A.E. EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 192 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 193 U.A.E. BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 194 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 195 U.A.E. AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 196 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 197 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 198 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 199 SAUDI ARABIA NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 200 SAUDI ARABIA HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 201 SAUDI ARABIA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 202 SAUDI ARABIA MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 203 SAUDI ARABIA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 204 SAUDI ARABIA BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 205 SAUDI ARABIA FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 206 SAUDI ARABIA COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 207 SAUDI ARABIA POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 208 SAUDI ARABIA OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 209 SAUDI ARABIA SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 210 SAUDI ARABIA CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 211 SAUDI ARABIA POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 212 SAUDI ARABIA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 213 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 214 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 215 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 216 SAUDI ARABIA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 217 SAUDI ARABIA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 218 SAUDI ARABIA BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 219 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 220 SAUDI ARABIA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 221 SAUDI ARABIA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 222 SAUDI ARABIA FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 223 SAUDI ARABIA LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 224 SAUDI ARABIA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 225 SAUDI ARABIA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 226 SAUDI ARABIA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 227 SAUDI ARABIA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 228 SAUDI ARABIA FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 229 SAUDI ARABIA RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 230 SAUDI ARABIA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 231 SAUDI ARABIA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 232 SAUDI ARABIA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 233 SAUDI ARABIA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 234 SAUDI ARABIA SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 235 SAUDI ARABIA SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 236 SAUDI ARABIA CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 237 SAUDI ARABIA RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 238 SAUDI ARABIA AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 239 SAUDI ARABIA JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 240 SAUDI ARABIA RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 241 SAUDI ARABIA RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 242 SAUDI ARABIA DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 243 SAUDI ARABIA CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 244 SAUDI ARABIA LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 245 SAUDI ARABIA SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 246 SAUDI ARABIA EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 247 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 248 SAUDI ARABIA BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 249 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 250 SAUDI ARABIA AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 251 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 252 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 253 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 254 EGYPT NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 255 EGYPT HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 256 EGYPT MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 257 EGYPT MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 258 EGYPT BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 259 EGYPT BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 260 EGYPT FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 261 EGYPT COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 262 EGYPT POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 263 EGYPT OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 264 EGYPT SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 265 EGYPT CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 266 EGYPT POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 267 EGYPT POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 268 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 269 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 270 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 271 EGYPT BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 272 EGYPT BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 273 EGYPT BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 274 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 275 EGYPT FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 276 EGYPT FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 277 EGYPT FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 278 EGYPT LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 279 EGYPT JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 280 EGYPT RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 281 EGYPT RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 282 EGYPT FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 283 EGYPT FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 284 EGYPT RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 285 EGYPT JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 286 EGYPT RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 287 EGYPT RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 288 EGYPT SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 289 EGYPT SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 290 EGYPT SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 291 EGYPT CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 292 EGYPT RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 293 EGYPT AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 294 EGYPT JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 295 EGYPT RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 296 EGYPT RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 297 EGYPT DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 298 EGYPT CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 299 EGYPT LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 300 EGYPT SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 301 EGYPT EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 302 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 303 EGYPT BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 304 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 305 EGYPT AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 306 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 307 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 308 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 309 ISRAEL NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 310 ISRAEL HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 311 ISRAEL MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 312 ISRAEL MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 313 ISRAEL BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 314 ISRAEL BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 315 ISRAEL FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 316 ISRAEL COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 317 ISRAEL POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 318 ISRAEL OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 319 ISRAEL SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 320 ISRAEL CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 321 ISRAEL POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 322 ISRAEL POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 323 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 324 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 325 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 326 ISRAEL BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 327 ISRAEL BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 328 ISRAEL BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 329 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 330 ISRAEL FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 331 ISRAEL FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 332 ISRAEL FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 333 ISRAEL LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 334 ISRAEL JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 335 ISRAEL RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 336 ISRAEL RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 337 ISRAEL FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 338 ISRAEL FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 339 ISRAEL RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 340 ISRAEL JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 341 ISRAEL RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 342 ISRAEL RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 343 ISRAEL SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 344 ISRAEL SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 345 ISRAEL SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 346 ISRAEL CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 347 ISRAEL RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 348 ISRAEL AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 349 ISRAEL JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 350 ISRAEL RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 351 ISRAEL RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 352 ISRAEL DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 353 ISRAEL CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 354 ISRAEL LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 355 ISRAEL SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 356 ISRAEL EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 357 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 358 ISRAEL BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 359 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 360 ISRAEL AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 361 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 362 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 363 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 364 BAHRAIN NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 365 BAHRAIN HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 366 BAHRAIN MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 367 BAHRAIN MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 368 BAHRAIN BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 369 BAHRAIN BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 370 BAHRAIN FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 371 BAHRAIN COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 372 BAHRAIN POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 373 BAHRAIN OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 374 BAHRAIN SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 375 BAHRAIN CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 376 BAHRAIN POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 377 BAHRAIN POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 378 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 379 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 380 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 381 BAHRAIN BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 382 BAHRAIN BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 383 BAHRAIN BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 384 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 385 BAHRAIN FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 386 BAHRAIN FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 387 BAHRAIN FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 388 BAHRAIN LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 389 BAHRAIN JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 390 BAHRAIN RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 391 BAHRAIN RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 392 BAHRAIN FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 393 BAHRAIN FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 394 BAHRAIN RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 395 BAHRAIN JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 396 BAHRAIN RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 397 BAHRAIN RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 398 BAHRAIN SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 399 BAHRAIN SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 400 BAHRAIN SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 401 BAHRAIN CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 402 BAHRAIN RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 403 BAHRAIN AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 404 BAHRAIN JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 405 BAHRAIN RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 406 BAHRAIN RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 407 BAHRAIN DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 408 BAHRAIN CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 409 BAHRAIN LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 410 BAHRAIN SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 411 BAHRAIN EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 412 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 413 BAHRAIN BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 414 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 415 BAHRAIN AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 416 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 417 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 418 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 419 TURKEY NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 420 TURKEY HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 421 TURKEY MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 422 TURKEY MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 423 TURKEY BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 424 TURKEY BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 425 TURKEY FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 426 TURKEY COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 427 TURKEY POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 428 TURKEY OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 429 TURKEY SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 430 TURKEY CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 431 TURKEY POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 432 TURKEY POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 433 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 434 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 435 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 436 TURKEY BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 437 TURKEY BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 438 TURKEY BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 439 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 440 TURKEY FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 441 TURKEY FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 442 TURKEY FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 443 TURKEY LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 444 TURKEY JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 445 TURKEY RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 446 TURKEY RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 447 TURKEY FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 448 TURKEY FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 449 TURKEY RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 450 TURKEY JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 451 TURKEY RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 452 TURKEY RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 453 TURKEY SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 454 TURKEY SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 455 TURKEY SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 456 TURKEY CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 457 TURKEY RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 458 TURKEY AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 459 TURKEY JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 460 TURKEY RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 461 TURKEY RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 462 TURKEY DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 463 TURKEY CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 464 TURKEY LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 465 TURKEY SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 466 TURKEY EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 467 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 468 TURKEY BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 469 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 470 TURKEY AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 471 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 472 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 473 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 474 KUWAIT NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 475 KUWAIT HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 476 KUWAIT MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 477 KUWAIT MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 478 KUWAIT BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 479 KUWAIT BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 480 KUWAIT FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 481 KUWAIT COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 482 KUWAIT POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 483 KUWAIT OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 484 KUWAIT SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 485 KUWAIT CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 486 KUWAIT POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 487 KUWAIT POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 488 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 489 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 490 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 491 KUWAIT BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 492 KUWAIT BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 493 KUWAIT BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 494 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 495 KUWAIT FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 496 KUWAIT FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 497 KUWAIT FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 498 KUWAIT LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 499 KUWAIT JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 500 KUWAIT RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 501 KUWAIT RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 502 KUWAIT FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 503 KUWAIT FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 504 KUWAIT RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 505 KUWAIT JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 506 KUWAIT RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 507 KUWAIT RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 508 KUWAIT SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 509 KUWAIT SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 510 KUWAIT SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 511 KUWAIT CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 512 KUWAIT RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 513 KUWAIT AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 514 KUWAIT JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 515 KUWAIT RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 516 KUWAIT RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 517 KUWAIT DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 518 KUWAIT CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 519 KUWAIT LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 520 KUWAIT SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 521 KUWAIT EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 522 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 523 KUWAIT BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 524 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 525 KUWAIT AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 526 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 527 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 528 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 529 OMAN NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 530 OMAN HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 531 OMAN MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 532 OMAN MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 533 OMAN BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 534 OMAN BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 535 OMAN FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 536 OMAN COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 537 OMAN POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 538 OMAN OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 539 OMAN SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 540 OMAN CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 541 OMAN POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 542 OMAN POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 543 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 544 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 545 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 546 OMAN BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 547 OMAN BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 548 OMAN BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 549 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 550 OMAN FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 551 OMAN FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 552 OMAN FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 553 OMAN LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 554 OMAN JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 555 OMAN RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 556 OMAN RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 557 OMAN FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 558 OMAN FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 559 OMAN RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 560 OMAN JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 561 OMAN RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 562 OMAN RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 563 OMAN SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 564 OMAN SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 565 OMAN SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 566 OMAN CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 567 OMAN RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 568 OMAN AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 569 OMAN JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 570 OMAN RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 571 OMAN RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 572 OMAN DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 573 OMAN CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 574 OMAN LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 575 OMAN SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 576 OMAN EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 577 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 578 OMAN BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 579 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 580 OMAN AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 581 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 582 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 583 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 584 QATAR NATURAL AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 585 QATAR HYALURONIC ACID (HA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 586 QATAR MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 587 QATAR MONOPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 588 QATAR BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY MATERIAL TYPE, 2018-2036 (USD THOUSAND)

TABLE 589 QATAR BIPHASIC FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 590 QATAR FAT IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 591 QATAR COLLAGEN IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 592 QATAR POLYNUCLEOTIDES / POLYDEOXYRIBONUCLEOTIDES (PN/PDRN) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 593 QATAR OTHERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 594 QATAR SYNTHETIC AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 595 QATAR CALCIUM HYDROXYLAPATITE (CAHA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 596 QATAR POLY-L-LACTIC ACID (PLLA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 597 QATAR POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 598 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 599 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 600 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 601 QATAR BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 602 QATAR BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 603 QATAR BIODEGRADABLE AESTHETIC INJECTABLE FILLERS IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (ASP IN USD/UNITS)

TABLE 604 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY APPLICATION, 2018-2036 (USD THOUSAND)

TABLE 605 QATAR FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 606 QATAR FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY LOCATION, 2018-2036 (USD THOUSAND)

TABLE 607 QATAR FACIAL LINE CORRECTION IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 608 QATAR LIP ENHANCEMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 609 QATAR JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 610 QATAR RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 611 QATAR RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 612 QATAR FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 613 QATAR FACE LIFT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 614 QATAR RHINOPLASTY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 615 QATAR JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 616 QATAR RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 617 QATAR RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 618 QATAR SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 619 QATAR SCAR TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY BRAND, 2018-2036 (USD THOUSAND)

TABLE 620 QATAR SAGGING SKIN IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 621 QATAR CHEEK DEPRESSION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 622 QATAR RECONSTRUCTIVE SURGERY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 623 QATAR AESTHETIC RESTORATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 624 QATAR JUVÉDERM IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 625 QATAR RESTYLANE IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 626 QATAR RHA IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 627 QATAR DENTISTRY IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 628 QATAR CHIN AUGMENTATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 629 QATAR LIPOATROPHY TREATMENT IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 630 QATAR SKIN SMOOTHENING IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 631 QATAR EARLOBE REJUVENATION IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 632 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY DRUG TYPE, 2018-2036 (USD THOUSAND)

TABLE 633 QATAR BRANDED IN AESTHETIC INJECTABLE FILLERS MARKET, BY TYPE, 2018-2036 (USD THOUSAND)

TABLE 634 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY END USER, 2018-2036 (USD THOUSAND)

TABLE 635 QATAR AESTHETIC INJECTABLE FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2018-2036 (USD THOUSAND)

TABLE 636 REST OF MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (USD THOUSAND)

TABLE 637 REST OF MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (VOLUME IN THOUSAND UNITS)

TABLE 638 REST OF MIDDLE EAST & NORTH AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE, 2018-2036 (ASP IN USD/UNITS)

List of Figure

FIGURE 1 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: MARKET END USER COVERAGE GRID

FIGURE 9 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: EXECUTIVE SUMMARY

FIGURE 11 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: SEGMENTATION

FIGURE 12 TWO SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET, BY PRODUCT TYPE (2024)

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 GROWING DEMAND FOR MINIMALLY INVASIVE COSMETIC PROCEDURES EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET IN THE FORECAST PERIOD OF 2025 TO 2036

FIGURE 15 NATURAL AESTHETIC INJECTABLE FILLERS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET IN 2025 & 2036

FIGURE 16 PORTER’S FIVE FORCES

FIGURE 17 PATENT FILINGS ACROSS SEVERAL KEY JURISDICTIONS:

FIGURE 18 KEY APPLICANTS V/S NUMBER OF PATENTS.

FIGURE 19 IPC CODES V/S PATENT COUNT.

FIGURE 20 YEAR V/S NUMBER OF PATENTS PUBLISHED

FIGURE 21 DROC ANALYSIS

FIGURE 22 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY TYPE, 2024

FIGURE 23 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY TYPE, 2025 TO 2036 (USD THOUSAND)

FIGURE 24 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY TYPE, CAGR (2025- 2036)

FIGURE 25 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 26 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY PRODUCT TYPE, 2024

FIGURE 27 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY PRODUCT TYPE, 2025 TO 2036 (USD THOUSAND)

FIGURE 28 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY PRODUCT TYPE, CAGR (2025- 2036)

FIGURE 29 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 30 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY DRUG TYPE, 2024

FIGURE 31 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY DRUG TYPE, 2025 TO 2036 (USD THOUSAND)

FIGURE 32 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY DRUG TYPE, CAGR (2025- 2036)

FIGURE 33 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY DRUG TYPE, LIFELINE CURVE

FIGURE 34 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY APPLICATION, 2024

FIGURE 35 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY APPLICATION, 2025 TO 2036 (USD THOUSAND)

FIGURE 36 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY APPLICATION, CAGR (2025- 2036)

FIGURE 37 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 38 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY END USER, 2024

FIGURE 39 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY END USER, 2025 TO 2036 (USD THOUSAND)

FIGURE 40 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY END USER, CAGR (2025- 2036)

FIGURE 41 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY END USER, LIFELINE CURVE

FIGURE 42 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 43 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2025 TO 2036 (USD THOUSAND)

FIGURE 44 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025- 2036)

FIGURE 45 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 46 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: SNAPSHOT (2024)

FIGURE 47 MIDDLE EAST AND AFRICA AESTHETIC INJECTABLE FILLERS MARKET: COMPANY SHARE 2024 (%)

View Detailed Information

Middle East And North Africa Aesthetic Injectable Fillers Market, Supply Chain Analysis and Ecosystem Framework

To support market growth and help clients navigate the impact of geopolitical shifts, DBMR has integrated in-depth supply chain analysis into its Middle East And North Africa Aesthetic Injectable Fillers Market research reports. This addition empowers clients to respond effectively to global changes affecting their industries. The supply chain analysis section includes detailed insights such as Middle East And North Africa Aesthetic Injectable Fillers Market consumption and production by country, price trend analysis, the impact of tariffs and geopolitical developments, and import and export trends by country and HSN code. It also highlights major suppliers with data on production capacity and company profiles, as well as key importers and exporters. In addition to research, DBMR offers specialized supply chain consulting services backed by over a decade of experience, providing solutions like supplier discovery, supplier risk assessment, price trend analysis, impact evaluation of inflation and trade route changes, and comprehensive market trend analysis.

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

What is the current market size of the Middle East and North Africa Aesthetic Injectable Fillers Market?

The Middle East and North Africa Aesthetic Injectable Fillers Market size was valued at USD 347.92 Million in 2024.

What is the expected growth rate of Middle East and North Africa Aesthetic Injectable Fillers Market?

the Middle East and North Africa Aesthetic Injectable Fillers Market is to grow at a CAGR of 9.33% during the forecast period of 2025 to 2036.

What are the primary segments covered in the Middle East and North Africa Aesthetic Injectable Fillers Market report?

The Aesthetic Injectable Fillers market is segmented into six notable segments which are based on product type, type, application, drug type, end users, and distribution channel. On the basis of Product Type market is segmented into Natural Aesthetic Injectable Fillers, and Synthetic Aesthetic Injectable Fillers, By Type market is segmented into Biodegradable Aesthetic Injectable Fillers, Non-Biodegradable Aesthetic Injectable Fillers, By Application market is segmented into Facial Line Correction, Lip Enhancement, Face Lift, Rhinoplasty, Scar Treatment, Sagging Skin, Cheek Depression, Reconstructive Surgery, Aesthetic Restoration, Dentistry, Chin Augmentation, Lipoatrophy Treatment, Skin Smoothing, Earlobe Rejuvenation, Others, By Drug Type market is segmented into Branded, and Generic, By End User market is segmented into Dermatology Clinics, Hospitals, Ambulatory Surgical Centers, and Others, By Distribution Channel market is segmented into Direct Tender/Direct Distribution, Drug Stores, Online Pharmacy, and Others.

Who are major players in Middle East and North Africa Aesthetic Injectable Fillers Market?

Allergan Aesthetics (AbbVie) (United States), GALDERMA (Switzerland), Merz Pharma (UAE), Hugel Inc. (Israel), and LG Chem (Israel)are major players in Middle East and North Africa Aesthetic Injectable Fillers Market.

What are the recent product launches by major companies in the Middle East and North Africa Aesthetic Injectable Fillers Market?

In May 2024, Galderma introduced Restylane VOLYME alongside its Shape Up HIT (Holistic Individualized Treatment) in UAE. This product launch is tailored specifically to address mid-face aging caused by loss of structural support. By combining volumizing filler with personalized treatment protocols, Galderma enhances its ability to meet the nuanced needs of both patients and injectors in the rapidly expanding Chinese aesthetic market.

Which countries data is covered in the Middle East and North Africa Aesthetic Injectable Fillers Market?

The countries covered in the Middle East and North Africa Aesthetic Injectable Fillers Market are U.S. and Canada. Europe comprises UAE, France, the U.K., Hungary, Lithuania, Austria, Ireland, Norway, Poland, Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and the rest of Europe. The Middle East & North Africa region includes Saudi Arabia, UAE, Israel, Egypt, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, and the rest of Middle East & North Africa. Latin America is segmented into Brazil, Mexico, Argentina, Chile, Colombia, Peru, Venezuela, Costa Rica, Ecuador, Uruguay, Bolivia, Panama, Guatemala, Honduras, El Salvador, Nicaragua, and the rest of Latin America. The Middle East and Africa segment includes South Africa, Saudi Arabia, U.A.E., Egypt, Kuwait, Israel, and the rest of Middle East and Africa. Russia and CIS is further segmented into Russia, Kazakhstan, Belarus, Uzbekistan, and the rest of CIS Countries.

Which country is expected to dominate in the Middle East and North Africa Aesthetic Injectable Fillers Market?

The UAE is expected to dominate the Middle East and North Africa Aesthetic Injectable Fillers Market, supported by its large and aging population, rising disposable income, and increasing social acceptance of cosmetic procedures.

Which country is expected to witness the highest CAGR in the Middle East and North Africa Aesthetic Injectable Fillers Market?

Saudi Arabia is expected to register the highest CAGR in the Middle East and North Africa Aesthetic Injectable Fillers Market, fueled by its rapidly aging population, increasing demand for minimally invasive anti-aging solutions, and a cultural preference for natural-looking enhancements.

What are the key trends in the Middle East and North Africa Aesthetic Injectable Fillers Market?

Key trends in the Middle East and North Africa Aesthetic Injectable Fillers Market include the rising demand for minimally invasive aesthetic procedures, advancements in filler technologies, and increasing consumer preference for personalized and natural-looking results.

What are the factors driving the Aesthetic Injectable Fillers market growth?

Growth in the Aesthetic Injectable Fillers market is driven by the Growing demand for minimally invasive cosmetic procedures, rising influence of social media and celebrity culture, increasing acceptance of cosmetic enhancements among millennials and gen z and rising popularity of combination treatments.

Middle East and North Africa Aesthetic Injectable Fillers Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2036

Circumvent the Tariff challenges with an agile supply chain Consulting

Middle East And North Africa Aesthetic Injectable Fillers Market

CAGR : 9.33 %

Middle East and North Africa Aesthetic Injectable Fillers Market Size

Middle East and North Africa Aesthetic Injectable Fillers Market Analysis

Report Scope and Middle East and North Africa Aesthetic Injectable Fillers Market Segmentation

Middle East and North Africa Aesthetic Injectable Fillers Key Market Insights

Middle East and North Africa Aesthetic Injectable Fillers Market Trends

Middle East and North Africa Aesthetic Injectable Fillers Market Dynamics

Middle East and North Africa Aesthetic Injectable Fillers Market Scope

Middle East and North Africa Aesthetic Injectable Fillers Market – Regional Analysis

Latest Developments in Middle East and North Africa Aesthetic Injectable Fillers Market

Get online access to the report on the World's First Market Intelligence Cloud

Table of Content

List of Table

List of Figure

Middle East And North Africa Aesthetic Injectable Fillers Market, Supply Chain Analysis and Ecosystem Framework

Research Methodology

Customization Available

Frequently Asked Questions

What is the current market size of the Middle East and North Africa Aesthetic Injectable Fillers Market?

What is the expected growth rate of Middle East and North Africa Aesthetic Injectable Fillers Market?

What are the primary segments covered in the Middle East and North Africa Aesthetic Injectable Fillers Market report?

Who are major players in Middle East and North Africa Aesthetic Injectable Fillers Market?

What are the recent product launches by major companies in the Middle East and North Africa Aesthetic Injectable Fillers Market?

Which countries data is covered in the Middle East and North Africa Aesthetic Injectable Fillers Market?

Which country is expected to dominate in the Middle East and North Africa Aesthetic Injectable Fillers Market?

Which country is expected to witness the highest CAGR in the Middle East and North Africa Aesthetic Injectable Fillers Market?

What are the key trends in the Middle East and North Africa Aesthetic Injectable Fillers Market?

What are the factors driving the Aesthetic Injectable Fillers market growth?

Industry Related Reports

Middle East and North Africa Aesthetic Injectable Fillers Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2036

Circumvent the Tariff challenges with an agile supply chain Consulting

Middle East And North Africa Aesthetic Injectable Fillers Market

CAGR : 9.33 %

Middle East and North Africa Aesthetic Injectable Fillers Market Size

Middle East and North Africa Aesthetic Injectable Fillers Market Analysis

Report Scope and Middle East and North Africa Aesthetic Injectable Fillers Market Segmentation

Middle East and North Africa Aesthetic Injectable Fillers Key Market Insights

Middle East and North Africa Aesthetic Injectable Fillers Market Trends

Middle East and North Africa Aesthetic Injectable Fillers Market Dynamics

Middle East and North Africa Aesthetic Injectable Fillers Market Scope

Middle East and North Africa Aesthetic Injectable Fillers Market – Regional Analysis

Latest Developments in Middle East and North Africa Aesthetic Injectable Fillers Market

Get online access to the report on the World's First Market Intelligence Cloud

Table of Content

List of Table

List of Figure

Middle East And North Africa Aesthetic Injectable Fillers Market, Supply Chain Analysis and Ecosystem Framework

Research Methodology

Customization Available

Frequently Asked Questions

What is the current market size of the Middle East and North Africa Aesthetic Injectable Fillers Market?

What is the expected growth rate of Middle East and North Africa Aesthetic Injectable Fillers Market?

What are the primary segments covered in the Middle East and North Africa Aesthetic Injectable Fillers Market report?

Who are major players in Middle East and North Africa Aesthetic Injectable Fillers Market?

What are the recent product launches by major companies in the Middle East and North Africa Aesthetic Injectable Fillers Market?

Which countries data is covered in the Middle East and North Africa Aesthetic Injectable Fillers Market?

Which country is expected to dominate in the Middle East and North Africa Aesthetic Injectable Fillers Market?

Which country is expected to witness the highest CAGR in the Middle East and North Africa Aesthetic Injectable Fillers Market?

What are the key trends in the Middle East and North Africa Aesthetic Injectable Fillers Market?

What are the factors driving the Aesthetic Injectable Fillers market growth?

Industry Related Reports

Browse Related Pages

Browse Related Blogs

Browse Related Infographics

Browse Related Press Release

Market Statistics